EUVIMEDOpdag EUVIMED
Fallbericht

Pituitary tumour shrinkage and diabetic remission in two cats with Cushing syndrome treated with cabergoline

S Teyssandier iD, S Galac

Journal of Small Animal Practice · 2026-08-10

DOI: 10.1111/jsap.70185 ↗

At a glance

Fallbericht in Journal of Small Animal Practice, published online on 2026-08-10. Written by S Teyssandier and 1 co-authors. Institution: Veterinary Endocrinology Center, Centro de endocrinologia de alta complejidad, Buenos Aires, Argentina. 20 references.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

We describe two cats with diabetes mellitus and Cushing's syndrome. Diabetes mellitus was initially managed with insulin glargine (Lantus; Sanofi‐Aventis, Paris, France), nutritional therapy and continuous glucose monitoring. Hypercortisolism was suspected based on severe hypertension (Case 1), and insulin resistance in combination with typical clinical features of Cushing's syndrome (Case 2). Endocrine testing revealed non‐suppressible cortisol concentrations on low‐dose‐dexamethasone suppression test, elevated endogenous adenocorticotrophic hormone (ACTH) concentration and pituitary enlargement on computed tomography. Cabergoline (Holiday®, Holliday‐Scott S.A., Buenos Aires, Argentina) was initiated at a dose of 10 μg/kg po every 48 hours targeting both the pituitary tumour and hypercortisolism. In Case 2, the cabergoline dosage was gradually increased to a final dose of 10 μg/kg po every 12 hours. Both cats achieved diabetic remission within 1 and 6 months of treatment, respectively. Serial monitoring demonstrated a decrease in endogenous ACTH concentrations and a reduction in pituitary volume of 29% of baseline (Case 1) and of 52% of baseline (Case 2) after 8 months of treatment. These findings suggest that cabergoline may be a potential medical treatment option in cats with pituitary‐dependent hypercortisolism.

Authors and institutions

  • Veterinary Endocrinology Center, Centro de endocrinologia de alta complejidad, Buenos Aires, Argentina.
  • Faculteit Diergeneeskunde, Utrecht, Netherlands.

ORCID profiles: S Teyssandier

Cite

APA

Teyssandier, S., & Galac, S. (2026). Pituitary tumour shrinkage and diabetic remission in two cats with Cushing syndrome treated with cabergoline. Journal of Small Animal Practice. https://doi.org/10.1111/jsap.70185

Vancouver

Teyssandier S, Galac S. Pituitary tumour shrinkage and diabetic remission in two cats with Cushing syndrome treated with cabergoline. Journal of Small Animal Practice. 2026. doi:10.1111/jsap.70185

BibTeX
@article{Teyssandier2026,
  author = {Teyssandier, S and Galac, S},
  title = {Pituitary tumour shrinkage and diabetic remission in two cats with Cushing syndrome treated with cabergoline},
  journal = {Journal of Small Animal Practice},
  year = {2026},
  doi = {10.1111/jsap.70185}
}
Start for free →